Cached score snapshot

US.SOLV · Solventum

110分制 61/110；5D動能v2 7/50；排序分 68/160

Back to ranking Open volume snapshot

Ranking score 68/160

Main score 61/110

5D momentum v2 7/50

Rank #200

Setup grade F 31.8

Score breakdown

觀望

Medium twelvedata

Score and price trend

F 31.8 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.504 · anchors 120	+1.30%	-1.81% / +3.05%	62.5%	2.5%	Actual -2.53% · vs median -3.83% · inside 25-75 band
30D observation	+1.02%	-2.33% / +6.31%	52.5%	12.5%	Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160	+0.83%	-1.08% / +2.51%	61.3%	1.3%	Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-07-22 → 2026-11-25 · 148 archived points · 6 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 68

Display grade 觀望

Model version cursor_18_27_news_v2_160

Main score 61/110 (觀望)

5D momentum v2 7/50 (弱)

Score with momentum v2 68/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 87.8285

ma50 88.3664

close 87.26

prevClose 86.3

avgVolume20 968012

volumeRatio 1.07

changePercent 1.11

Metrics snapshot

close 87.26

volume 1031145

changePercent 1.11

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 61/110

Main rating 觀望

5D momentum v2 7/50

Score with momentum v2 68/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.4/5 · 一般

Dimension score 3.4/5

Dimension grade 一般

Sub-items

pbPoints 0.4

pePoints 0.5

epsPoints 0

roePoints 0.75

debtPoints 0.4

marginPoints 0.4

turnoverUsdM 89.9777

volumePoints 0.5

revenuePoints 0

dividendPoints 0

marketCapPoints 0.4

資金流 — 10/20 · 較差

Dimension score 10/20

Dimension grade 較差

Sub-items

cmfPoints 1.6

mfiPoints 1.6

obvPoints 4

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.SOLV

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 9/15 · 一般

Dimension score 9/15

Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred

vixClose 15.27

trend

score 2.8

details

qqq

ma20 742.542

ma50 726.6542

name QQQ

close 728.84

points 1.4

spy

ma20 770.6465

ma50 768.568

name SPY

close 769.6

points 1.4

source twelvedata+fred

atrPct 2.2089

atrPoints 3

cciPoints 0.8

vixPoints 2.4

marketTrendPoints 2.8

催化劑 — 6/20 · 較差

Dimension score 6/20

Dimension grade 較差

Sub-items

catalyst

score 6

details

source finnhub_news_keyword_model

articleCount 4

catalystCount 1

catalystPoints 6

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10

Dimension grade 良好

Sub-items

position

score 1.4

details

atrPct 2.2089

turnoverUsdM 89.9777

liquidityPoints 0.4

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.SOLV

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 83.405

strength_details

ma_score 1

atr_score 2

rsi_score 1

macd_score 1

volume_score 2

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.4

take_profit_price 91.623

target_multiplier 1.6

technical_strength 1.35

take_profit_percent 5

positionPoints 1.4

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.4178

diversificationPoints 2

技術信號 — 17.4/30 · 較差

Dimension score 17.4/30

Dimension grade 較差

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 3

vcpPoints 2.1

macdPoints 0.8

vcpPayload

vcp_pass false

vcp_score 2.1

vcp_reason 波幅收縮(12.5%→7%)；靠近20日高位；升放量(近10日4日)；Ready=N；Confirm=Y

vcp_metrics

up_days 5

vol_ref 929366.6667

down_days 4

vcp_ready false

above_ma50 false

avg_vol_10 1008390

avg_vol_20 965320

avg_vol_30 929366.6667

range_pct_10 0.0702

range_pct_20 0.0983

range_pct_30 0.1246

up_expand_ok true

lookback_used 59

near_20d_high true

contraction_ok true

down_shrink_ok false

up_expand_days 4

breakout_20d_ok false

vol_ratio_10_30 1.085

dist_to_20d_high 0.0502

down_shrink_days 2

breakout_level_20d 91.87

vcp_breakout_confirm true

contraction_ratio_10_30 0.5639

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction true

kdjAdxPoints 0.7

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 0

shortRsiPoints 0.8

shortMacdPoints 0.4

volConfirmPoints 0.6

volumePointsTechnical 1.2

情緒分析 — 8/10 · 優秀

Dimension score 8/10

Dimension grade 優秀

Sub-items

sentiment

score 8

details

source finnhub_news_keyword_model

articleCount 4

negativeHits 0

positiveHits 3

sentimentScoreRaw 1.8

sentimentData

raw {"id":142731298,"url":"https://finnhub.io/api/news?id=287790e36248c60a41d2a7f1df63357af715c4c5136d3b666c0b0bb6ab03a3e3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1791472203,"headline":"Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?"}, {"id":142357926,"url":"https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"SOLV","summary":"SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.","category":"company","datetime":1790167847,"headline":"Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"}, {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}

raw_source {"id":142886345,"url":"https://finnhub.io/api/news?id=2eb132da1e00b89ebe033b6e08337f524981d6412c48c58cd5cbcdcc18f6afed","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296348532/image_1296348532.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Want to retire on income? Learn how a dividend portfolio using preferred shares and baby bonds can boost yield on cost and preserve principal.","category":"company","datetime":1791986068,"headline":"How To Retire: Hope For 95, Prepare For 105"}, {"id":142731298,"url":"https://finnhub.io/api/news?id=287790e36248c60a41d2a7f1df63357af715c4c5136d3b666c0b0bb6ab03a3e3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1791472203,"headline":"Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?"}, {"id":142694288,"url":"https://finnhub.io/api/news?id=bcf3d87d4790c76efdb9f81b82b264678fd2118cba6bdac7427e6d2884743781","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1687462580/image_1687462580.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Seeking Alpha welcomed 38 new analysts in September 2026. Read more on companies Qualcomm, Teladoc, and NewLake Capital Partners, as well as the TDAQ ETF here.","category":"company","datetime":1791363600,"headline":"Stock Picks From Seeking Alpha's September 2026 New Analysts"}, {"id":142579894,"url":"https://finnhub.io/api/news?id=0613a86b53a573fec02adc8ae9d3c3067853745781de94ad372e7e197d859984","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.","category":"company","datetime":1790928843,"headline":"3 Overrated Stocks We Approach with Caution"}, {"id":142489804,"url":"https://finnhub.io/api/news?id=16afab250e596ae592f9f7bca2764d37cfadace1234ef8315eb5c9c600155286","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1790676482,"headline":"2 Profitable Stocks for Long-Term Investors and 1 We Question"}, {"id":142424992,"url":"https://finnhub.io/api/news?id=5eb60055313d744943696a26eaf89c292827c6847a58d2d6b72496d7a5f99fc2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Despite lagging behind other healthcare stocks over the past year, analysts remain fairly optimistic about Solventum, supported by the stock's bullish momentum and rosy outlook.","category":"company","datetime":1790332329,"headline":"How Is Solventum's Stock Performance Compared to Other Healthcare Stocks"}, {"id":142374869,"url":"https://finnhub.io/api/news?id=d3b72d9e0ee2fe8729fb0d6df4aa15bc8c0069a5604947b123cadf844aab3431","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The global ostomy dressings market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a 4.4% CAGR. Growth is driven by rising colorectal cancer and inflammatory bowel disease cases, aging populations, improved peristomal skin care awareness, and expanding home care services. Skin barrier rings will record the fastest product growth, while Asia Pacific will be the fastest-growing region. Key companies include Coloplast, ConvaTec, Hollister, B. Braun, Solventum, and","category":"company","datetime":1790245560,"headline":"Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare"}, {"id":142374481,"url":"https://finnhub.io/api/news?id=9f8e62e8512c4a3b32abc3255b280672b837dbae0b100d026ec4b3a966308fcc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"The global temperature management systems market is projected to grow from USD 3.56 billion in 2026 to USD 4.58 billion by 2031, at a 5.2% CAGR. Growth is driven by rising surgical volumes, cardiovascular and neurological disorders, perioperative hypothermia prevention, and targeted temperature management in critical care. Patient warming systems and perioperative care led in 2025, while Asia Pacific is expected to grow fastest. Key players include Solventum, GE HealthCare, Dräger, Ecolab, Medtr","category":"company","datetime":1790244900,"headline":"Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic"}, {"id":142357926,"url":"https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860","image":"https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp","source":"ChartMill","related":"SOLV","summary":"SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.","category":"company","datetime":1790167847,"headline":"Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"}, {"id":142252751,"url":"https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"SOLV","summary":"Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.","category":"company","datetime":1789717319,"headline":"Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"}, {"id":142231517,"url":"https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.","category":"company","datetime":1789660260,"headline":"Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"}, {"id":142223244,"url":"https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...","category":"company","datetime":1789625565,"headline":"What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"}, {"id":142198487,"url":"https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"SOLV","summary":"As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).","category":"company","datetime":1789577572,"headline":"Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"}, {"id":142138123,"url":"https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff","image":"","source":"Benzinga","related":"SOLV","summary":"BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.","category":"company","datetime":1789367355,"headline":"BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"}

data_source finnhub_news_keyword_model

article_count 4

negative_hits 0

positive_hits 3

recomputed_at_score true

sentiment_score_raw 1.8

source_article_count 14

discarded_article_count 10

sentimentPoints 8

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 3.4 5/110 68% 3.4

資金流 10 20/110 50% 10

市場環境 9 15/110 60% 9

催化劑 6 20/110 30% 6

風險管理 7.2 10/110 72% 7.2

技術信號 17.4 30/110 58% 17.4

情緒分析 8 10/110 80% 8

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50

ret_5d 0.0161

max_score 50

max_total 50

raw_total 7

vcp_bonus 0

vol_ratio 1.0682

ret_points 4

vol_points 2

range_ratio 0.7691

volat_points 0

day_range_pct 0.0167

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 1

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.4

details

atrPct 2.2089

turnoverUsdM 89.9777

liquidityPoints 0.4

volatilityPoints 1

rrPoints 1.4

stopLevels

symbol US.SOLV

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 83.405

strength_details

ma_score 1

atr_score 2

rsi_score 1

macd_score 1

volume_score 2

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 4.4

take_profit_price 91.623

target_multiplier 1.6

technical_strength 1.35

take_profit_percent 5

positionPoints 1.4

stopLossPoints 2.4

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 4.4178

diversificationPoints 2

Calculation audit log

基本面分析總分: 3.4/5分
資金流分析總分: 10/20分
市場環境分析總分: 9/15分
催化劑分析: 6/20分
風險管理總分: 7.2/10分
技術信號分析總分: 17.4/30分
情緒分析: 8/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 100

atr

atr 1.9275

rule ATR / current price; lower volatility scores higher

score 6

atr_pct 2.21

cci

rule Cursor_18.24 CCI bands

level 超買或超賣風險

score 2

value -64.12

cmf

rule Cursor_18.24 CMF bands

level 平衡

score 4

value 0.0157

kdj

d 38.76

j 64.67

k 47.4

rule Cursor_18.24 K/D cross

score 4

signal 金叉

mfi

rule Cursor_18.24 MFI bands

level 弱流入

score 4

value 41.74

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 10

trend 強流入

value 5730945

recentSlope 294104.5

previousSlope 34770

rsi

value 43.65

sar

rule Cursor_18.24 Parabolic SAR

score 10

trend 上升

value 83.29

position SAR由上轉下+趨勢強

distancePct 4.55

previousTrend 下降

ma50

value 88.3664

macd

macd -0.56

trend 看跌

signal -0.3391

histogram -0.2209

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 87.6522

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 有量

ratio 1.07

score 6

avgVolume 968012

currentVolume 1031145

derived

ma20 87.8285

ma50 88.3664

prevClose 86.3

avgVolume10 1042535

avgVolume20 968012

changePercent 1.11

avgVolumeForScore 968012

ma_cross

ma20 87.8285

ma50 88.3664

rule Cursor_18.24 MA20/MA50 cross

cross 熊勢

score 0

prevMa20 87.907

prevMa50 88.38

spreadPct 0.61

isVolumeBreakout false

bollinger

lower 85.4758

upper 90.1812

position 中間

rsi_short

value 51.69

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 1.07

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.208915883566353,
        "turnoverUsdM": 89.9777127,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.SOLV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 83.405,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.4,
      "take_profit_price": 91.623,
      "target_multiplier": 1.6,
      "technical_strength": 1.35,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.417831767132706,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 68,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 61,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 87.8285,
    "ma50": 88.3664,
    "close": 87.26,
    "prevClose": 86.3,
    "avgVolume20": 968012,
    "volumeRatio": 1.07,
    "changePercent": 1.11
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.01606893339543558,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 1.0681898230638545,
      "ret_points": 4,
      "vol_points": 2,
      "range_ratio": 0.7690506145909259,
      "volat_points": 0,
      "day_range_pct": 0.016731606692642766,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 68,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 68,
        "contribution": 3.4
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 9,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 60,
        "contribution": 9
      },
      {
        "raw": 6,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 30,
        "contribution": 6
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 17.4,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 58,
        "contribution": 17.4
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 61,
    "details": [
      "基本面分析總分: 3.4/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 9/15分",
      "催化劑分析: 6/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 17.4/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 6,
      "基本面": 3.4,
      "資金流": 10,
      "市場環境": 9,
      "情緒分析": 8,
      "技術信號": 17.4,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "catalystCount": 1
            }
          },
          "catalystPoints": 6
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.5,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 89.9777127,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.SOLV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.27
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 742.5420041499999,
                "ma50": 726.6542014600002,
                "name": "QQQ",
                "close": 728.84003,
                "points": 1.4
              },
              "spy": {
                "ma20": 770.64649665,
                "ma50": 768.5679965799999,
                "name": "SPY",
                "close": 769.59998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.208915883566353,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 4,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142731298,
                "url": "https://finnhub.io/api/news?id=287790e36248c60a41d2a7f1df63357af715c4c5136d3b666c0b0bb6ab03a3e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1791472203,
                "headline": "Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?"
              },
              {
                "id": 142357926,
                "url": "https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.",
                "category": "company",
                "datetime": 1790167847,
                "headline": "Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"
              },
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              }
            ],
            "raw_source": [
              {
                "id": 142886345,
                "url": "https://finnhub.io/api/news?id=2eb132da1e00b89ebe033b6e08337f524981d6412c48c58cd5cbcdcc18f6afed",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1296348532/image_1296348532.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Want to retire on income? Learn how a dividend portfolio using preferred shares and baby bonds can boost yield on cost and preserve principal.",
                "category": "company",
                "datetime": 1791986068,
                "headline": "How To Retire: Hope For 95, Prepare For 105"
              },
              {
                "id": 142731298,
                "url": "https://finnhub.io/api/news?id=287790e36248c60a41d2a7f1df63357af715c4c5136d3b666c0b0bb6ab03a3e3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Solventum (SOLV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
                "category": "company",
                "datetime": 1791472203,
                "headline": "Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive?"
              },
              {
                "id": 142694288,
                "url": "https://finnhub.io/api/news?id=bcf3d87d4790c76efdb9f81b82b264678fd2118cba6bdac7427e6d2884743781",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1687462580/image_1687462580.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Seeking Alpha welcomed 38 new analysts in September 2026. Read more on companies Qualcomm, Teladoc, and NewLake Capital Partners, as well as the TDAQ ETF here.",
                "category": "company",
                "datetime": 1791363600,
                "headline": "Stock Picks From Seeking Alpha's September 2026 New Analysts"
              },
              {
                "id": 142579894,
                "url": "https://finnhub.io/api/news?id=0613a86b53a573fec02adc8ae9d3c3067853745781de94ad372e7e197d859984",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1790928843,
                "headline": "3 Overrated  Stocks We Approach with Caution"
              },
              {
                "id": 142489804,
                "url": "https://finnhub.io/api/news?id=16afab250e596ae592f9f7bca2764d37cfadace1234ef8315eb5c9c600155286",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1790676482,
                "headline": "2 Profitable Stocks for Long-Term Investors and 1 We Question"
              },
              {
                "id": 142424992,
                "url": "https://finnhub.io/api/news?id=5eb60055313d744943696a26eaf89c292827c6847a58d2d6b72496d7a5f99fc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Despite lagging behind other healthcare stocks over the past year, analysts remain fairly optimistic about Solventum, supported by the stock's bullish momentum and rosy outlook.",
                "category": "company",
                "datetime": 1790332329,
                "headline": "How Is Solventum's Stock Performance Compared to Other Healthcare Stocks"
              },
              {
                "id": 142374869,
                "url": "https://finnhub.io/api/news?id=d3b72d9e0ee2fe8729fb0d6df4aa15bc8c0069a5604947b123cadf844aab3431",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The global ostomy dressings market is projected to grow from USD 3.80 billion in 2026 to USD 4.73 billion by 2031, at a 4.4% CAGR. Growth is driven by rising colorectal cancer and inflammatory bowel disease cases, aging populations, improved peristomal skin care awareness, and expanding home care services. Skin barrier rings will record the fastest product growth, while Asia Pacific will be the fastest-growing region. Key companies include Coloplast, ConvaTec, Hollister, B. Braun, Solventum, and",
                "category": "company",
                "datetime": 1790245560,
                "headline": "Ostomy Dressing Market Forecasts Growth from $3.80B (2026) to $4.73B by 2031, Profiling Coloplast, ConvaTec, Hollister, B. Braun & Salts Healthcare"
              },
              {
                "id": 142374481,
                "url": "https://finnhub.io/api/news?id=9f8e62e8512c4a3b32abc3255b280672b837dbae0b100d026ec4b3a966308fcc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "The global temperature management systems market is projected to grow from USD 3.56 billion in 2026 to USD 4.58 billion by 2031, at a 5.2% CAGR. Growth is driven by rising surgical volumes, cardiovascular and neurological disorders, perioperative hypothermia prevention, and targeted temperature management in critical care. Patient warming systems and perioperative care led in 2025, while Asia Pacific is expected to grow fastest. Key players include Solventum, GE HealthCare, Dräger, Ecolab, Medtr",
                "category": "company",
                "datetime": 1790244900,
                "headline": "Temperature Management Systems Market Forecasts Growth from $3.56B (2026) to $4.58B by 2031, Profiling 3M, Asahi-Kasei, GE Healthcare, Dragerwerk & Medtronic"
              },
              {
                "id": 142357926,
                "url": "https://finnhub.io/api/news?id=fdca5f63b7d3d0ef3a66907f2d6ea673fdd6123a21fbd41d64b51e3dfc7c2860",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "SOLV",
                "summary": "SOLV stock: Solventum technical breakout setup with strong trend, tight consolidation, ChartMill ratings 8/10 and 9/10, defined entry/risk levels.",
                "category": "company",
                "datetime": 1790167847,
                "headline": "Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds"
              },
              {
                "id": 142252751,
                "url": "https://finnhub.io/api/news?id=8dffac6f353cafa877be7a43649e86347a4a64618a16a41f9143e33d6c293069",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304057123/image_1304057123.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "SOLV",
                "summary": "Solventum trades at a significant discount to medical technology peers, with a forward P/E of ~13x and suppressed EV/EBITDA multiples. Learn more about SOLV stock here.",
                "category": "company",
                "datetime": 1789717319,
                "headline": "Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play"
              },
              {
                "id": 142231517,
                "url": "https://finnhub.io/api/news?id=d2fbcf5a6ad084f6029a82395e4b80e290f082b45503961eff049d8b5a9b6b6c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.",
                "category": "company",
                "datetime": 1789660260,
                "headline": "Here's Why You Should Hold Solventum Stock in Your Portfolio for Now"
              },
              {
                "id": 142223244,
                "url": "https://finnhub.io/api/news?id=59633399520a47eacff7f99436994f965caf02cf678587f2923d18419da155f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "Earlier this quarter, Solventum reported results that surpassed analyst expectations, with both organic revenue and EPS beating estimates and management emphasizing strong execution and ongoing transformation efforts. An interesting angle is how Solventum’s exposure to surgical equipment and consumables, including AI and robotics-enabled solutions, supports relatively consistent procedural demand and innovation-driven opportunities. Now we’ll explore how this stronger-than-expected quarter,...",
                "category": "company",
                "datetime": 1789625565,
                "headline": "What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders"
              },
              {
                "id": 142198487,
                "url": "https://finnhub.io/api/news?id=05a6bd6f2bd1d52654aa9e5f44225f78f2e05bf22c065fd021b67ffb8936e3c4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "SOLV",
                "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables - diversified stocks, starting with Solventum (NYSE:SOLV).",
                "category": "company",
                "datetime": 1789577572,
                "headline": "Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses"
              },
              {
                "id": 142138123,
                "url": "https://finnhub.io/api/news?id=996fef6f894db5de5b3f7384dca6b49a263730212beb8addd07e9b0e2bdef5ff",
                "image": "",
                "source": "Benzinga",
                "related": "SOLV",
                "summary": "BTIG  analyst Ryan Zimmerman   reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.",
                "category": "company",
                "datetime": 1789367355,
                "headline": "BTIG Reiterates Buy on Solventum, Maintains $95 Price Target"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 4,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 14,
            "discarded_article_count": 10
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.4,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 3,
          "vcpPoints": 2.1,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.1,
            "vcp_reason": "波幅收縮(12.5%→7%)；靠近20日高位；升放量(近10日4日)；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 929366.6666666666,
              "down_days": 4,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1008390,
              "avg_vol_20": 965320,
              "avg_vol_30": 929366.6666666666,
              "range_pct_10": 0.07024982809993119,
              "range_pct_20": 0.0983268393307357,
              "range_pct_30": 0.12457024982809982,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 4,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.085029231376206,
              "dist_to_20d_high": 0.05017960161097202,
              "down_shrink_days": 2,
              "breakout_level_20d": 91.87,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.5639374425023
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.208915883566353,
              "turnoverUsdM": 89.9777127,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.SOLV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 83.405,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.4,
            "take_profit_price": 91.623,
            "target_multiplier": 1.6,
            "technical_strength": 1.35,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.417831767132706,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 100,
    "atr": {
      "atr": 1.9275,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.21
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -64.12
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0157
    },
    "kdj": {
      "d": 38.76,
      "j": 64.67,
      "k": 47.4,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 41.74
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 5730945,
      "recentSlope": 294104.5,
      "previousSlope": 34770
    },
    "rsi": 43.65,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 10,
      "trend": "上升",
      "value": 83.29,
      "position": "SAR由上轉下+趨勢強",
      "distancePct": 4.55,
      "previousTrend": "下降"
    },
    "ma50": 88.3664,
    "macd": {
      "macd": -0.5599614820879708,
      "trend": "看跌",
      "signal": -0.3390953659435783,
      "histogram": -0.2208661161443925
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 87.6522,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.07,
      "score": 6,
      "avgVolume": 968012,
      "currentVolume": 1031145
    },
    "derived": {
      "ma20": 87.8285,
      "ma50": 88.3664,
      "prevClose": 86.3,
      "avgVolume10": 1042535,
      "avgVolume20": 968012,
      "changePercent": 1.11,
      "avgVolumeForScore": 968012
    },
    "ma_cross": {
      "ma20": 87.8285,
      "ma50": 88.3664,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 87.907,
      "prevMa50": 88.38,
      "spreadPct": 0.61,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 85.4758,
      "upper": 90.1812,
      "position": "中間"
    },
    "rsi_short": 51.69,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.07
    }
  }
}

Raw metrics JSON

{
  "close": 87.26,
  "volume": 1031145,
  "changePercent": 1.11
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.

US.SOLV · Solventum

觀望

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 3.4/5 · 一般

Sub-items

資金流 — 10/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 9/15 · 一般

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 6/20 · 較差

Sub-items

catalyst

details

風險管理 — 7.2/10 · 良好

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 17.4/30 · 較差

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 8/10 · 優秀

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON